Výsledky vyhledávání - Maureen Howard

  • Zobrazuji výsledky 1 - 9 z 9
Upřesnit hledání
  1. 1
    The Earliest T Lineage–Committed Cells Depend on IL-7 for Bcl-2 Expression and Normal Cell Cycle Progression

    The Earliest T Lineage–Committed Cells Depend on IL-7 for Bcl-2 Expression and Normal Cell Cycle Progression Autor Ursula von Freeden-Jeffry, Nanette Solvason, Maureen Howard, Richard Murray

    Vydáno 1997
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Proteolytic Activation of Alternative CCR1 Ligands in Inflammation

    Proteolytic Activation of Alternative CCR1 Ligands in Inflammation Autor Robert Berahovich, Zhenhua Miao, Yu Wang, Brett A. Premack, Maureen Howard, Thomas J. Schall

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Arrest of B Lymphocyte Terminal Differentiation by CD40 Signaling: Mechanism for Lack of Antibody-Secreting Cells in Germinal Centers

    Arrest of B Lymphocyte Terminal Differentiation by CD40 Signaling: Mechanism for Lack of Antibody-Secreting Cells in Germinal Centers Autor Troy D. Randall, Andrew W. Heath, Leopoldo Santos‐Argumedo, Maureen Howard, Irving L. Weissman, Frances E. Lund

    Vydáno 1998
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer

    Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer Autor Runzhe Shu, Vera Evtimov, Maree V. Hammett, Nhu-Y. N. Nguyen, Junli Zhuang, Peter J. Hudson, Maureen Howard, Aleta Pupovac, Alan Trounson, Richard L. Boyd

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

    Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential Autor Jie Liu, Lijuan Wang, Feifei Zhao, Serena Tseng, Cyndhavi Narayanan, Lei Shura, Stephen B. Willingham, Maureen Howard, Susan Prohaska, Jens Volkmer, Mark P. Chao, Irving L. Weissman, Ravindra Majeti

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    CXCR7 (RDC1) promotes breast and lung tumor growth <i>in vivo</i> and is expressed on tumor-associated vasculature

    CXCR7 (RDC1) promotes breast and lung tumor growth <i>in vivo</i> and is expressed on tumor-associated vasculature Autor Zhenhua Miao, Kathryn E. Luker, Bretton C. Summers, Rob Berahovich, Mahaveer S. Bhojani, Alnawaz Rehemtulla, Celina G. Kleer, Jeffrey J. Essner, Aidas Nasevicius, Gary D. Luker, Maureen Howard, Thomas J. Schall

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development

    Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development Autor Nanette Solvason, Wei Wu, David Parry, Daniel Mahony, Eric W.‐F. Lam, Janet Glassford, G. G. B. Klaus, Piotr Siciński, Robert A. Weinberg, Yong-Jun Liu, Maureen Howard, Emma Lees

    Vydáno 2000
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

    A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development Autor Jennifer M. Burns, Bretton C. Summers, Yu Wang, Anita Melikian, Rob Berahovich, Zhenhua Miao, Mark E.T. Penfold, Mary Jean Sunshine, Dan R. Littman, Calvin J. Kuo, Kevin Wei, Brian E. McMaster, K Wright, Maureen Howard, Thomas J. Schall

    Vydáno 2006
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

    First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers Autor Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik, Sumit Shah, Sreenivasa R Chandana, Drew Rasco, A. Dimitrios Colevas, Timothy J. O’Rourke, Sujata Narayanan, Kyriakos P. Papadopoulos, George A. Fisher, Víctor M. Villalobos, Susan Prohaska, Maureen Howard, Muralidhar Beeram, Mark P. Chao, Balaji Agoram, James Y. Chen, Jie Huang, Matthew Axt, Jie Liu, Jens-Peter Volkmer, Ravindra Majeti, Irving L. Weissman, Chris H. Takimoto, Dana Supan, Heather A. Wakelee, Rhonda Aoki, Mark D. Pegram, Sukhmani K. Padda

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: